CLINICAL_TRIALS
trial_result
· 2019-12-30
Clinical Trial Update: IVIG in Patients With VGKC Ab Associated Autoimmune Epilepsy [Phase 3]
Summary
Phase 3 trial of intravenous immunoglobulin (IVIG) in VGKC-complex antibody-associated autoimmune epilepsy was terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Autoimmune Epilepsy | Phase 3 | Status: TERMINATED | Results posted: 2019-12-30